Min Yan

Zhengzhou University

SCHOLARLY PAPERS

2

DOWNLOADS

138

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial

Number of pages: 37 Posted: 15 Jul 2024
Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Zhengzhou University, Anyang Tumor Hospital, China Medical University, Xinxiang Medical University, Henan University of Science and Technology, Henan University - Department of Breast and Thyroid Surgery, Duke University - Duke Cancer Institute, Duke University and Zhengzhou University
Downloads 90 (620,226)

Abstract:

Loading...

Breast cancer, Her2 positive, Neoadjuvant, Nab-paclitaxel, De-escalation

2.

ARX788 Versus Lapatinib Plus Capecitabine in the Second-Line Treatment of HER2-Positive Advanced Breast Cancer (ACE-Breast-02): A Multicentre, Open-Label, Phase III, Randomised Controlled Trial

Number of pages: 26 Posted: 10 Jul 2024
Fudan University - Department of Medical Oncology, Harbin Medical University - Cancer Hospital, Fudan University - Department of Oncology, Fudan University - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital, Jilin Central Hospital, Guangxi Medical University, Tianjin Medical University - Tianjin Cancer Institute, Sun Yat-sen University (SYSU) - Sun Yat-Sen University Cancer Center, Chongqing University Cancer Hospital, Dalian University of Technology - Liaoning Cancer Institute and Hospital, Xinjiang Medical University, Anhui Medical University - Second Affiliated Hospital, Hainan Medical University - First Affiliated Hospital, Sun Yat-sen University, Hainan Medical University - Hainan General Hospital, Zhengzhou University, Henan University of Science and Technology - Department of Medical Oncology, Linyi Cancer Hospital - Department of Breast Surgery, Wenzhou Medical University, Anhui Medical University - Department of Oncology, Government of the People's Republic of China - Beijing Hospital, Xiamen University - First Affiliated Hospital, Xinxiang Medical University - First Affiliated Hospital, Xuzhou Central Hospital, Sanmenxia Central Hospital, Hebei University - Department of Medical Oncology, Hebei University and Hebei University
Downloads 48 (867,673)

Abstract:

Loading...

HER2-positive, antibody-drug conjugates, advanced breast cancer.